In a large study, men who underwent radical prostatectomy at centers that had the largest annual prostate cancer caseload lived a median 13.2 months longer than those who had the surgery at centers with the lowest caseload.
Men with chronic kidney disease (CKD) at the time of radical prostatectomy are 5 times more likely to experience postoperative complications than those without CKD, a study found.
In a study, men with a higher preoperative hemoglobin A1c level had greater risks for developing castration-resistant prostate cancer and metastasis.
Prostate mpMRI findings before and after neoadjuvant therapy prior to robotic prostatectomy could be useful in assessing whether high-risk patients are suitable surgical candidates.
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
Canadian study shows that nearly all men undergoing radical prostatectomy in Eastern Ontario in recent years have clinically significant prostate cancer.
In a study, nearly 20% of radical cystectomy patients were readmitted for complications within 90 days compared with 1.9% and 5.9% for radical prostatectomy and radical nephrectomy, respectively.
Among patients with high-risk prostate cancer, investigators observe no significant difference in cancer-related death risk between radiotherapy and radical prostatectomy.
Patients with a relatively low tumor risk and good general health status appear to experience the best survival.
